CLICK HERE TO SEE MORE
We hope that you can find here all information you need about our H2020 supported programme CCHFVaccine, aiming at increasing European capacity to control the situation of Crimean Congo Hemorrhagic fever disease on a global basis by developing and deliver a vaccine.
Contact us for any additional question
Launch of Phase I clinical trial using DNA vaccine, in May 2024
A follow-up project has received funding under Horizon Europe.
Phase I clinical trial application submitted, Q1 2024 !